American Conference Institute’s Pharmaceutical Antitrust Forum

“Assessing What the Authorized Generic Drug Study and Report on Intellectual Property Collectively Mean for the Pharmaceutical Industry”

May 20-21, 2008
National Harbor, MD

Washington partner Howard Morse will participate in a panel discussion along with representatives from the Federal Trade Commission, Pfizer and Wyeth. The discussion will include updates on FTC policy initiatives and on the Authorized Generic Drug Study.